MyFinsight
Home
Blog
About
Contact
Download
Download image
Total comprehensive
loss
-$26,550K
Foreign currency
translation adjustment
-$632K
Net loss
attributable to common...
-$27,182K
(-39.35%↓ Y/Y)
Net loss
-$26,829K
(-38.48%↓ Y/Y)
Deemed dividend
related to warrant...
$353K
(167.42%↑ Y/Y)
Loss from operations
-$14,320K
(3.25%↑ Y/Y)
Total other expense
-$12,509K
(-173.54%↓ Y/Y)
Research and other
$200K
(-43.98%↓ Y/Y)
Total operating costs
and expenses
$14,520K
(-4.21%↓ Y/Y)
Loss from
extinguishment of debt
-$4,004K
(41.29%↑ Y/Y)
Change in fair value of
derivative liabilities
-$3,332K
(-109.56%↓ Y/Y)
Interest expense
$2,621K
(26.01%↑ Y/Y)
Loss from issuance of
debt
-$1,611K
Foreign currency
transaction gain (loss)
-$808K
Change in fair value of
share payable
-$118K
(-268.57%↓ Y/Y)
Change in fair value of
convertible notes
-$15K
(-100.49%↓ Y/Y)
Research and development
$7,450K
(-8.36%↓ Y/Y)
General and
administrative
$7,070K
(0.60%↑ Y/Y)
Back
Back
Income Statement
source: myfinsight.com
NORTHWEST BIOTHERAPEUTICS INC (NWBO)
NORTHWEST BIOTHERAPEUTICS INC (NWBO)